文献速递其他结缔组织病

巨噬细胞转录组变化与系统性硬化症相关并介导GSDMA对疾病风险的贡献

Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk.
PubMed 文献 · Ann Rheum Dis · 2018-01-17

研究对57例系统性硬化症(SSc)患者和15例对照的单核细胞来源巨噬细胞(MDM)进行RNA测序和全基因组基因分型,鉴定出602个差异表达基因和270个顺式调控基因,发现GSDMA在SSc MDM中上调且为显著eQTL,并揭示以糖酵解、缺氧和mTOR信号上调及IFNγ反应通路下调为特征的SSc巨噬细胞转录组特征。

要点

  • SSc患者MDM中鉴定出602个上调和下调基因,显著富集于既往SSc易感基因(P=5×10-4)。
  • GSDMA在SSc MDM中上调(P=8.4×10-4),但在皮肤中未上调,且为SSc巨噬细胞的显著eQTL。
  • SSc巨噬细胞转录组特征为糖酵解、缺氧和mTOR信号上调及IFNγ反应通路下调。

核心结论

  • 数据进一步确立巨噬细胞与SSc之间的联系,并提示rs3894194风险变异对SSc易感性的贡献可能由巨噬细胞中GSDMA表达介导。

研究设计与样本

  • 对57例SSc患者和15例对照的单核细胞来源巨噬细胞(MDM)进行RNA测序和全基因组基因分型。
  • 将SSc中的差异表达和表达数量性状基因座(eQTL)分析与来自皮肤、单核细胞、中性粒细胞和淋巴细胞的表观遗传、表达及eQTL数据整合。

主要发现

  • 在SSc巨噬细胞中鉴定出602个上调和下调基因,显著富集于既往SSc易感基因(P=5×10-4),以及270个MDM中的顺式调控基因。
  • GSDMA在SSc MDM中上调(P=8.4×10-4),但在皮肤中未上调,且在SSc巨噬细胞和脂多糖/干扰素γ(IFNγ)刺激的单核细胞中为显著eQTL。
  • 鉴定出SSc巨噬细胞转录组特征:糖酵解、缺氧和mTOR信号上调,IFNγ反应通路下调。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Several common and rare risk variants have been reported for systemic sclerosis (SSc), but the effector cell(s) mediating the function of these genetic variants remains to be elucidated. While innate immune cells have been proposed as the critical targets to interfere with the disease process underlying SSc, no studies have comprehensively established their effector role. Here we investigated the contribution of monocyte-derived macrophages (MDMs) in mediating genetic susceptibility to SSc. METHODS: We carried out RNA sequencing and genome-wide genotyping in MDMs from 57 patients with SSc and 15 controls. Our differential expression and expression quantitative trait locus (eQTL) analysis in SSc was further integrated with epigenetic, expression and eQTL data from skin, monocytes, neutrophils and lymphocytes. RESULTS: We identified 602 genes upregulated and downregulated in SSc macrophages that were significantly enriched for genes previously implicated in SSc susceptibility (P=5×10-4), and 270 cis-regulated genes in MDMs. Among these, GSDMA was reported to carry an SSc risk variant (rs3894194) regulating expression of neighbouring genes in blood. We show that GSDMA is upregulated in SSc MDMs (P=8.4×10-4) but not in the skin, and is a significant eQTL in SSc macrophages and lipopolysaccharide/interferon gamma (IFNγ)-stimulated monocytes. Furthermore, we identify an SSc macrophage transcriptome signature characterised by upregulation of glycolysis, hypoxia and mTOR signalling and a downregulation of IFNγ response pathways. CONCLUSIONS: Our data further establish the link between macrophages and SSc, and suggest that the contribution of the rs3894194 risk variant to SSc susceptibility can be mediated by GSDMA expression in macrophages.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Moreno-Moral A, Bagnati M, Koturan S, et al. Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk. Ann Rheum Dis. 2018. PMID: 29348297. doi:10.1136/annrheumdis-2017-212454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。